Cargando…

Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial

BACKGROUND: Increasing buprenorphine/naloxone (B/N) access for opioid use disorder (OUD) is essential yet ensuring adherence and preventing diversion remains challenging. This study examines the feasibility, usability, and acceptability of MySafeRx, a mobile platform integrating motivational coachin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janzow, Grace E., Harding, Cassandra, Flores, Michael, Borodovsky, Jacob, Steinkamp, Jackson, Marsch, Lisa A., Schuman-Olivier, Zev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949338/ https://www.ncbi.nlm.nih.gov/pubmed/36845988 http://dx.doi.org/10.1016/j.dadr.2022.100045

Ejemplares similares

MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study
por: Schuman-Olivier, Zev, et al.
Publicado: (2018)

Technological Interventions for Medication Adherence in Adult Mental Health and Substance Use Disorders: A Systematic Review
por: Steinkamp, Jackson M, et al.
Publicado: (2019)

Trends in Buprenorphine Prescribing for Opioid Use Disorder by Psychiatrists in the US From 2003 to 2021
por: Creedon, Timothy B., et al.
Publicado: (2023)

Emergency-department initiated buprenorphine: Impact on quality of life
por: Carroll, Caleb, et al.
Publicado: (2023)

Online self-exclusion from multiple gambling venues: Stakeholder co-design of a usable and acceptable self-directed website
por: Pickering, D., et al.
Publicado: (2021)

The introduction of a novel formulation of buprenorphine into organized health systems()()
por: Mullen, William, et al.
Publicado: (2022)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use
por: Winstanley, Erin L., et al.
Publicado: (2022)

An observational study on the use of long acting buprenorphine (Sublocade) and a Tamper resistant PICC for Outpatient IV antibiotic administration in Patients with serious infections and Opioid Use Disorder; The STOP OUD project
por: Pineo, Thomas, et al.
Publicado: (2021)

Effectiveness, acceptance and satisfaction of guided chat groups in psychosocial aftercare for outpatients with prostate cancer after prostatectomy
por: Lange, Lukas, et al.
Publicado: (2017)

Usability and acceptability testing of a Plan of Safe Care in a mobile health platform
por: Isaacs, Krystyna R., et al.
Publicado: (2023)

State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements
por: Silwal, Anita, et al.
Publicado: (2023)

A chatbot-delivered intervention for optimizing social media use and reducing perceived isolation among rural-living LGBTQ+ youth: Development, acceptability, usability, satisfaction, and utility
por: Escobar-Viera, César G., et al.
Publicado: (2023)

“I don’t want to take buprenorphine for the rest of my life”: Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design)
por: Shepherd, Kate, et al.
Publicado: (2021)

Changes in buprenorphine visits in frontier and remote locations: Effects of the SARS-CoV-2 pandemic
por: McFadden, Lisa M.
Publicado: (2023)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022)

Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design
por: Roy, Payel Jhoom, et al.
Publicado: (2023)

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023)

Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort
por: Wang, Xi, et al.
Publicado: (2023)

My care manager, my computer therapy and me: The relationship triangle in computerized cognitive behavioural therapy
por: Cavanagh, Kate, et al.
Publicado: (2017)

Outpatient Microdose Induction with Transdermal Buprenorphine: A Case Series
por: Menard, Shannon, et al.
Publicado: (2022)

Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program
por: Ward, Kathleen M., et al.
Publicado: (2022)

Buprenorphine involvement in opioid overdose deaths: A retrospective analysis of postmortem toxicology in Marion County, Indiana, 2015-2021
por: del Pozo, Brandon, et al.
Publicado: (2023)

Sex specific effects of buprenorphine on behavior, astrocytic opioid receptor expression and neuroinflammation after pediatric traumatic brain injury in mice
por: Hamood, Yesmine, et al.
Publicado: (2022)

Users’ perceptions of the “My Medicine” mobile app usability
por: Irnawati,, et al.
Publicado: (2022)

Buprenorphine Outpatient Outcomes Project: can Suboxone be a viable outpatient option for heroin addiction?
por: Sittambalam, Charmian D., et al.
Publicado: (2014)

TRAAC framework to improve regulatory acceptance and wider usability of tools and methods for safe innovation and sustainability of manufactured nanomaterials
por: Shandilya, Neeraj, et al.
Publicado: (2023)

User feedback and usability testing of an online training and support program for dementia carers
por: Teles, Soraia, et al.
Publicado: (2021)

2537: Usability and adoption of the first enterprise-wide app prescribing platform, RxUniverse, in an academic tertiary care hospital
por: Makhni, Sonya, et al.
Publicado: (2018)

The feasibility, acceptability, and usability of telehealth visits
por: Sinha Gregory, Naina, et al.
Publicado: (2023)

Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018
por: Golan, Olivia K., et al.
Publicado: (2023)

Development and usability testing of a web-based smoking cessation treatment for smokers with schizophrenia
por: Brunette, Mary F., et al.
Publicado: (2016)

Rx.NET in action
por: Dresher, Tamir
Publicado: (2017)

RxJS in action
por: Daniels, Paul P, et al.
Publicado: (2017)

RxJava essentials
por: Morgillo, Ivan
Publicado: (2015)

Learning RxJava
por: Samoylov, Nick
Publicado: (2020)

Rx—The Eye of Horus
por: Walker, Clive
Publicado: (1992)

A Mobile Sexual Health App on Empowerment, Education, and Prevention for Young Adult Men (MyPEEPS Mobile): Acceptability and Usability Evaluation
por: Gannon, Brittany, et al.
Publicado: (2020)

When a pandemic and epidemic collide: Lessons learned about how system barriers can interrupt implementation of addiction research
por: Sharp, Amanda, et al.
Publicado: (2023)

Association of chronic non-cancer pain status and buprenorphine treatment retention among individuals with opioid use disorder: Results from electronic health record data
por: John, William S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aqiala8lvh10rdniqhu633pstm